AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Eisai Inc. Assumes U.S. Distribution Responsibilities for Aciphex(R); Company Accomplishes Long-Term Goal for Aricept(R) and Aciphex(R).

PR Newswire

| January 07, 2004 | COPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

TEANECK, N.J., Jan. 7 /PRNewswire/ -- Eisai Inc. announced today that the company has assumed the U.S. distribution responsibilities for Aciphex(R) (rabeprazole sodium) from Janssen Pharmaceutica, Inc. affiliate JOM Pharmaceutical Services. Eisai and Janssen will continue to co-promote Aciphex(R), a proton pump inhibitor (PPI) prescribed for gastroesophageal reflux disease (GERD), in the United States. The partnership with Janssen for sales, marketing and further clinical development remains unchanged for the duration of the co-promotion agreement.

Effective December 29, 2003, Eisai is fulfilling purchase orders for Aciphex(R) from a contract distribution center in Memphis, Tenn. Aciphex(R) was discovered and developed by Eisai and is manufactured and packaged in its Research Triangle Park, N.C., facility.

"The transition of the distribution of Aciphex(R) to Eisai marks the accomplishment of an important long-term goal in the company's quest to achieve independence and growth in the manufacturing, distribution and promotion of its own products," said Bill Sheldon, president and COO of Eisai Inc. "The distribution of Aricept(R) (donepezil hydrochloride tablets), and now, Aciphex(R), further enhances Eisai's capabilities as a licensee and committed partner."

Eisai's distribution contractor is centrally located in Memphis to ensure a quick turn-around time for customer orders. Eisai's return goods policy and terms and conditions of sales to direct U.S. and Puerto Rico customers will apply to Aciphex(R) sales after December 29, 2003, and these policies and terms are posted on Eisai's web site (http://www.eisai.com/, Pharmacy Trade Relations). All Aricept(R) and Aciphex(R) returns can be processed through Universal Solution Inc.'s One Box Returns Program.

About Eisai Inc.

Eisai Inc. is a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., a research-based human health care company that discovers, develops and markets products in more than 30 countries. Established in 1995, Eisai Inc. began marketing its first product, Aricept(R), in the United States in 1997 and has rapidly grown to become an integrated pharmaceutical business with sales of nearly $1.5 billion in fiscal year 2002 (year ending March 31, 2003).

Drawing on the R&D strengths of its global parent company, Eisai focuses its efforts in four therapeutic areas: neurology, gastrointestinal disorders, oncology and acute care. Eisai Inc. employs more than 850 people at its headquarters in Teaneck, N.J., at its state-of-the-art pharmaceutical production and formulation research and development facility in Research Triangle Park, N.C., and in the field. Between 1998 and 2002, Eisai Inc. moved up rapidly in the rankings of U.S. pharmaceutical companies (based on revenues) from No. 44 to 23.

Related articles from newspapers, magazines, journals, and more
U.S. Federal Circuit Court of Appeals Fully Upholds Eisai's Favorable Ruling in...
Press release article from: PR Newswire July 21, 2008 700+ words
...summary judgment to Eisai, upholding the validity of the Aciphex(R) composition...and Germany. Aciphex(R) was discovered and developed by Eisai and is copromoted...http://www.aciphex.com/. About Eisai Co., Ltd. Eisai...
Eisai Obtains Favorable Ruling in Aciphex(R) Patent Infringement Lawsuit...
Press release article from: PR Newswire May 11, 2007 700+ words
...Chairman & CEO of Eisai Inc. Aciphex(R) is classified as a...In the United States, Eisai Inc. copromotes Aciphex(R) with PriCara(TM...please visit http://www.eisai.com/. About Aciphex(R) Aciphex(R) has...
Eisai Receives Summary Judgment Motion Decisions in U.S. Legal Action Over...
Press release article from: PR Newswire October 9, 2006 700+ words
...New York granted Eisai's summary judgment...validity of the Aciphex(R) composition...http://www.aciphex.com/ or http://www.eisai.com/. CONTACT...http://www.aciphex.com/ http://www.eisai.com/
U.S. Federal Circuit Court of Appeals Fully Upholds Eisai's Favorable Ruling in...
Newspaper article from: Biotech Week August 6, 2008 700+ words
...summary judgment to Eisai, upholding the validity of the Aciphex(R) composition...Eisai Inc. "Eisai will continue...the world." Aciphex(R) is classified...and Germany. Aciphex(R) was discovered...and developed by Eisai and is copromoted...
Eisai Inc assumes US distribution responsibilities for Aciphex.
News wire article from: Asia Africa Intelligence Wire January 7, 2004 700+ words
...Pharmaceutical Services. Eisai and Janssen will...to co-promote Aciphex, a proton pump...29 Dec 2003, Eisai is fulfilling purchase orders for Aciphex from a contract...Memphis, TN. Aciphex was discovered and developed by Eisai and is manufactured...
Eisai affirms Aciphex patent in US Court.
Newspaper article from: Pharma Marketletter July 28, 2008 700+ words
...its patent concerning Aciphex/Pariet (rabeprazole sodium) tablets. Eisai filed the infringement...summary judgment to Eisai, upholding the validity of the Aciphex composition-of...also determined that Eisai's patent is enforceable...
Eisai Inc. Ensuring That Products - Aricept(R), Aciphex(R) and Zonegran(R) -...
Press release article from: PR Newswire January 14, 2005 700+ words
...donepezil HCl tablets), Aciphex(R) (rabeprazole sodium...R) (zonisamide). Eisai remains committed to...US with Pfizer Inc. Aciphex is a registered trademark of Eisai Co., Ltd., Tokyo, Japan. Aciphex(R) is copromoted in...
FDA priority review for Eisai's Aciphex.
Newspaper article from: Pharma Marketletter March 10, 2008 700+ words
Japanese drug major Eisai says that the US Food and Drug Administration has accepted an Aciphex (rabeprazole sodium) supplemental New...Aciphex was discovered and developed by Eisai and is co-promoted in the USA with...
Eisai's Aciphex cleared for GERD by US FDA.
Newspaper article from: Pharma Marketletter July 7, 2008 700+ words
...unit of Japanese drugmaker Eisai says that the Food and Drug Administration has approved Aciphex (rabeprazole sodium) 20mg...without regard to relationship to Aciphex that occurred in greater than...once-daily treatment with Aciphex 20mg for eight weeks reduced...
Eisai, Janssen Revamp Aciphex Packaging.(Brief Article)
Magazine article from: Chain Drug Review August 27, 2001 700+ words
...TEANECK, N.J.--Eisai Inc. and Janssen...revised look for Aciphex (rabeprazole sodium...coded blue or red Aciphex brand labels to easily...90-count sizes. Aciphex is comarketed in the United States by Eisai and Janssen.
For more facts and information, see all results

Source: HighBeam Research, Eisai Inc. Assumes U.S. Distribution Responsibilities for Aciphex(R);...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA